Industry giants Tilray have raised €20 million to serve the EU medical cannabis market.
Canadian supplier Canopy extend their European reach with a deal to supply cannabis seeds to Spanish pharmaceutical producer.
Cannabis biotech companies are taking a leading stance in the global legal marketplace.
In a rapidly growing market, these three cannabis stocks claim the fastest revenue growth.
Attitudes across Europe are changing fast and, although currently illegal, we believe there is a 60%-70% probability of widespread legalisation within the next 3-5 years.
Find out more at prohibitionpartners.com